Seller record · Telehealth service

Stealth Health

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S3, pharmacy identification: The treatment, company and terms pages describe pharmacy partners without naming a dispensing facility. 3 more criteria also fail; see the table below.

At a glance

Stealth HealthTelehealth service

4/8criteria passed

Price: Printed on its own pages before sign-up
Sells: semaglutide with B12 and glycine, tirzepatide with glycine, sermorelin
FDA letters: None on file

Visit Stealth Health See all eight dispositions

Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A cross-border telehealth platform whose U.S. service lists compounded weight-loss and wellness prescriptions, with pharmacy payment collected separately after prescribing.

Operating entity Stealth Health Holdco, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Stealth Health's terms; Stealth Health's telehealth consent
S2	Prescription gating	PASS	Stealth Health's weight loss page; Stealth Health's growth hormone support page
S3	Pharmacy identification	FAIL	Stealth Health's weight loss page; Stealth Health's about page; Stealth Health's terms
S4	Compounding disclosure	FAIL	Stealth Health's weight loss page; Stealth Health's terms
S5	Analytical documentation	FAIL	Stealth Health's weight loss page; Stealth Health's growth hormone support page
S6	Business address	FAIL	Stealth Health's terms; Stealth Health's privacy policy
S7	Price disclosure	PASS	Stealth Health's weight loss page; Stealth Health's growth hormone support page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSLicensed providers evaluate patients and issue prescriptions; the platform does not dispense medication itself.Source: Stealth Health's terms; Stealth Health's telehealth consent.

S2PASSThe treatment pages describe clinician prescribing followed by pharmacy contact to confirm the prescription and collect payment.Source: Stealth Health's weight loss page; Stealth Health's growth hormone support page.

S3FAILThe treatment, company and terms pages describe pharmacy partners without naming a dispensing facility.Source: Stealth Health's weight loss page; Stealth Health's about page; Stealth Health's terms.

S4FAILThe terms say compounded medications are not FDA-approved in the same manner as manufactured products, but the treatment pages do not provide a plain not-FDA-approved disclosure beside the compounded options.Source: Stealth Health's weight loss page; Stealth Health's terms.

S5FAILThe weight-loss and growth-hormone treatment pages publish no certificate of analysis or equivalent lot document.Source: Stealth Health's weight loss page; Stealth Health's growth hormone support page.

S6FAILThe terms and privacy policy name a Delaware U.S. company and an Ontario Canadian company without publishing a U.S. street address for the operating business.Source: Stealth Health's terms; Stealth Health's privacy policy.

S7PASSThe weight-loss page lists semaglutide with B12 and glycine from $100 a month and tirzepatide with glycine from $175 a month. Sermorelin is advertised from $114.93 a month.Source: Stealth Health's weight loss page; Stealth Health's growth hormone support page.

S8PASSNo FDA warning letter names Stealth Health, Stealth Health Inc. or Stealth Health Holdco LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide with B12 and glycine, tirzepatide with glycine, sermorelin.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin

Visit Stealth Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.